Are you a medical professional looking for more information about certolizumab? Look no further! This ultimate guide has everything you need to know about this medication, including its uses, potential side effects, and who should avoid it. Whether you're new to prescribing certolizumab or simply want to refresh your knowledge on the topic, this comprehensive guide will provide you with all the necessary information. So sit back, relax, and let's dive into the world of certolizumab!
Certolizumab is a medication that belongs to a class of drugs called tumor necrosis factor (TNF) inhibitors. It works by blocking the action of TNF, which is a protein produced by the body's immune system and can cause inflammation.
This medication is used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease and ulcerative colitis.
Unlike other TNF inhibitors, certolizumab has been developed without any mouse or human-derived components. Instead, it consists solely of recombinant humanized antibodies fused with polyethylene glycol (PEG), which helps extend its half-life in the bloodstream.
As with any medication, certolizumab may cause side effects. Common side effects of certolizumab include redness, swelling, itching or pain at the injection site. These symptoms are usually mild and go away within a few days.
Other common side effects of certolizumab include headache and upper respiratory tract infections such as sinusitis or the common cold. These side effects may also be mild and typically resolve on their own.
Less common but potentially serious side effects of certolizumab include severe allergic reactions such as difficulty breathing, chest tightness or swelling of the face, lips or tongue.
Certolizumab is a medication that works by suppressing the activity of tumor necrosis factor-alpha (TNF-alpha), which is associated with various inflammatory and autoimmune diseases. However, not everyone can take certolizumab safely.
If you are allergic to certolizumab or any of its ingredients, you should not take this medication as it may cause an allergic reaction. Additionally, if you have a current or past history of tuberculosis (TB) or other infections such as hepatitis.
Pregnant women must avoid using certolizumab unless absolutely necessary because there is insufficient data on its safety in pregnancy. Similarly, breastfeeding mothers must also exercise caution when using this drug since it can pass into breast milk and potentially harm nursing infants.
Certolizumab is a highly effective medication for treating various autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and psoriatic arthritis. It works by blocking the action of TNF-alpha in the body which reduces inflammation and helps to alleviate symptoms.
While certolizumab can be an excellent option for patients who have not responded well to other treatments, it does come with some potentially serious side effects that need to be considered carefully before starting treatment.
1.
Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Access to GLP-1 medications associated with a lower risk of colorectal cancer in people with type 2 diabetes: JAMA.
4.
A garden can save your life
5.
Effective Intralesional Melanoma Therapy May Involve Systemic Effects.
1.
Precision Oncology Advances: Neoantigen Therapies, TCR Strategies & Radiotherapy Innovations
2.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
3.
Building Physical Resilience in Chronic Blood Disorders
4.
Advanced Approaches in Oncology and Patient Outcomes
5.
Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Common side effects of cancer treatment and how they are managed
2.
Case-Based Learning: Oncology
3.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
4.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
5.
Understanding the Importance of Follow-Up After Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation